Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Preferential Small Intestine Homing and Persistence of CD8 T Cells in Rhesus Macaques Achieved by Molecularly Engineered Expression of CCR9 and Reduced Ex Vivo Manipulation.

Trivett MT, Burke JD, Deleage C, Coren LV, Hill BJ, Jain S, Barsov EV, Breed MW, Kramer JA, Del Prete GQ, Lifson JD, Swanstrom AE, Ott DE.

J Virol. 2019 Oct 15;93(21). pii: e00896-19. doi: 10.1128/JVI.00896-19. Print 2019 Nov 1.

PMID:
31434738
2.

A PLPPV sequence in the p8 region of Gag provides late domain function for mouse mammary tumor virus.

Coren LV, Nagashima K, Ott DE.

Virology. 2019 Jul 19;535:272-278. doi: 10.1016/j.virol.2019.07.015. [Epub ahead of print]

PMID:
31357166
3.

T-cell responses to KSHV infection: a systematic approach.

Roshan R, Labo N, Trivett M, Miley W, Marshall V, Coren L, Cornejo Castro EM, Perez H, Holdridge B, Davis E, Matus-Nicodemos R, Ayala VI, Sowder R 2nd, Wyvill KM, Aleman K, Fennessey C, Lifson J, Polizzotto MN, Douek D, Keele B, Uldrick TS, Yarchoan R, Ohlen C, Ott D, Whitby D.

Oncotarget. 2017 Nov 25;8(65):109402-109416. doi: 10.18632/oncotarget.22683. eCollection 2017 Dec 12.

4.

CXCR5-Dependent Entry of CD8 T Cells into Rhesus Macaque B-Cell Follicles Achieved through T-Cell Engineering.

Ayala VI, Deleage C, Trivett MT, Jain S, Coren LV, Breed MW, Kramer JA, Thomas JA, Estes JD, Lifson JD, Ott DE.

J Virol. 2017 May 12;91(11). pii: e02507-16. doi: 10.1128/JVI.02507-16. Print 2017 Jun 1.

5.

A novel SIV gag-specific CD4(+)T-cell clone suppresses SIVmac239 replication in CD4(+)T cells revealing the interplay between antiviral effector cells and their infected targets.

Ayala VI, Trivett MT, Coren LV, Jain S, Bohn PS, Wiseman RW, O'Connor DH, Ohlen C, Ott DE.

Virology. 2016 Jun;493:100-12. doi: 10.1016/j.virol.2016.03.013. Epub 2016 Mar 25.

6.

Potent restriction of HIV-1 and SIVmac239 replication by African green monkey TRIM5α.

Coren LV, Trivett MT, Jain S, Ayala VI, Del Prete GQ, Ohlen C, Ott DE.

Retrovirology. 2015 Feb 7;12:11. doi: 10.1186/s12977-015-0137-9.

7.

Production of retroviral constructs for effective transfer and expression of T-cell receptor genes using Golden Gate cloning.

Coren LV, Jain S, Trivett MT, Ohlen C, Ott DE.

Biotechniques. 2015 Mar 1;58(3):135-9. doi: 10.2144/000114265. eCollection 2015 Mar.

8.

Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transfer.

Miller Jenkins LM, Ott DE, Hayashi R, Coren LV, Wang D, Xu Q, Schito ML, Inman JK, Appella DH, Appella E.

Nat Chem Biol. 2010 Dec;6(12):887-9. doi: 10.1038/nchembio.456. Epub 2010 Oct 17.

9.

Nef-mediated MHC class I down-regulation unmasks clonal differences in virus suppression by SIV-specific CD8(+) T cells independent of IFN-gamma and CD107a responses.

Minang JT, Trivett MT, Coren LV, Barsov EV, Piatak M Jr, Ott DE, Ohlen C.

Virology. 2009 Aug 15;391(1):130-9. doi: 10.1016/j.virol.2009.06.008. Epub 2009 Jun 24.

10.
11.
12.

Real-time visualization of HIV-1 GAG trafficking in infected macrophages.

Gousset K, Ablan SD, Coren LV, Ono A, Soheilian F, Nagashima K, Ott DE, Freed EO.

PLoS Pathog. 2008 Mar 7;4(3):e1000015. doi: 10.1371/journal.ppat.1000015.

13.

The Mamu B 17-restricted SIV Nef IW9 to TW9 mutation abrogates correct epitope processing and presentation without loss of replicative fitness.

Minang JT, Trivett MT, Coren LV, Barsov EV, Piatak M Jr, Chertov O, Chertova E, Ott DE, Ohlen C.

Virology. 2008 May 25;375(1):307-14. doi: 10.1016/j.virol.2008.02.005. Epub 2008 Mar 6.

14.

Mutational analysis of the C-terminal gag cleavage sites in human immunodeficiency virus type 1.

Coren LV, Thomas JA, Chertova E, Sowder RC 2nd, Gagliardi TD, Gorelick RJ, Ott DE.

J Virol. 2007 Sep;81(18):10047-54. Epub 2007 Jul 18.

15.

Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages.

Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, Bess JW Jr, Sowder RC 2nd, Barsov E, Hood BL, Fisher RJ, Nagashima K, Conrads TP, Veenstra TD, Lifson JD, Ott DE.

J Virol. 2006 Sep;80(18):9039-52.

16.

Characterization of human immunodeficiency virus type 1 (HIV-1) containing mutations in the nucleocapsid protein at a putative HIV-1 protease cleavage site.

Thomas JA, Shulenin S, Coren LV, Bosche WJ, Gagliardi TD, Gorelick RJ, Oroszlan S.

Virology. 2006 Oct 25;354(2):261-70. Epub 2006 Aug 9.

17.
18.
19.

Dynamic fluorescent imaging of human immunodeficiency virus type 1 gag in live cells by biarsenical labeling.

Rudner L, Nydegger S, Coren LV, Nagashima K, Thali M, Ott DE.

J Virol. 2005 Apr;79(7):4055-65.

20.

Quantitation of HLA class II protein incorporated into human immunodeficiency type 1 virions purified by anti-CD45 immunoaffinity depletion of microvesicles.

Trubey CM, Chertova E, Coren LV, Hilburn JM, Hixson CV, Nagashima K, Lifson JD, Ott DE.

J Virol. 2003 Dec;77(23):12699-709.

21.
22.

Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant.

Ott DE, Coren LV, Chertova EN, Gagliardi TD, Nagashima K, Sowder RC 2nd, Poon DT, Gorelick RJ.

J Virol. 2003 May;77(10):5547-56.

23.

Retroviruses have differing requirements for proteasome function in the budding process.

Ott DE, Coren LV, Sowder RC 2nd, Adams J, Schubert U.

J Virol. 2003 Mar;77(6):3384-93.

24.

Equine infectious anemia virus and the ubiquitin-proteasome system.

Ott DE, Coren LV, Sowder RC 2nd, Adams J, Nagashima K, Schubert U.

J Virol. 2002 Mar;76(6):3038-44.

26.

Ubiquitination of HIV-1 and MuLV Gag.

Ott DE, Coren LV, Chertova EN, Gagliardi TD, Schubert U.

Virology. 2000 Dec 5;278(1):111-21.

28.

Actin-binding cellular proteins inside human immunodeficiency virus type 1.

Ott DE, Coren LV, Johnson DG, Kane BP, Sowder RC 2nd, Kim YD, Fisher RJ, Zhou XZ, Lu KP, Henderson LE.

Virology. 2000 Jan 5;266(1):42-51.

29.

Comparison of the effect of FK506 and cyclosporin A on virus production in H9 cells chronically and newly infected by HIV-1.

Briggs CJ, Ott DE, Coren LV, Oroszlan S, Tözsér J.

Arch Virol. 1999;144(11):2151-60.

PMID:
10603169
30.
31.

Nucleocapsid protein zinc-finger mutants of simian immunodeficiency virus strain mne produce virions that are replication defective in vitro and in vivo.

Gorelick RJ, Benveniste RE, Gagliardi TD, Wiltrout TA, Busch LK, Bosche WJ, Coren LV, Lifson JD, Bradley PJ, Henderson LE, Arthur LO.

Virology. 1999 Jan 20;253(2):259-70.

32.
33.

Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus.

Ott DE, Coren LV, Copeland TD, Kane BP, Johnson DG, Sowder RC 2nd, Yoshinaka Y, Oroszlan S, Arthur LO, Henderson LE.

J Virol. 1998 Apr;72(4):2962-8.

34.

Cytoskeletal proteins inside human immunodeficiency virus type 1 virions.

Ott DE, Coren LV, Kane BP, Busch LK, Johnson DG, Sowder RC 2nd, Chertova EN, Arthur LO, Henderson LE.

J Virol. 1996 Nov;70(11):7734-43.

35.

Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS.

Rice WG, Supko JG, Malspeis L, Buckheit RW Jr, Clanton D, Bu M, Graham L, Schaeffer CA, Turpin JA, Domagala J, Gogliotti R, Bader JP, Halliday SM, Coren L, Sowder RC 2nd, Arthur LO, Henderson LE.

Science. 1995 Nov 17;270(5239):1194-7.

PMID:
7502043
36.

Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain.

Ott DE, Coren LV, Johnson DG, Sowder RC 2nd, Arthur LO, Henderson LE.

AIDS Res Hum Retroviruses. 1995 Sep;11(9):1003-6.

PMID:
8554896

Supplemental Content

Support Center